USANA Health Sciences Inc (USNA) stock
USNANYSEMedicinal Chemicals & Botanical ProductsFiscal year ends January 3
Financials through Q2 FY2026, quarter ended Jul 4, 2026Last filing: 10-Q on Nov 12, 2026Score 11/3058% below fair value
$13.57+0.03 (+0.22%)
Close on Nov 17, 2026Market cap $250.73MP/E –Yield –
USANA Health Sciences price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
USANA Health Sciences's price to sales ratio was 0.3× on Nov 11, 2026, against 0.4× a year earlier. Over the last 5 years it ranged from 0.3× to 1.6×, with a median of 0.9×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.3× | −0.1 |
| 2025 | Dec 31, 2025 | 0.4× | −0.4 |
| 2024 | Dec 31, 2024 | 0.8× | −0.3 |
| 2023 | Dec 29, 2023 | 1.1× | +0.1 |
| 2022 | Dec 30, 2022 | 1.0× | −0.6 |
| 2021 | Dec 31, 2021 | 1.6× | +0.1 |
| 2020 | Dec 31, 2020 | 1.5× | −0.1 |
| 2019 | Dec 31, 2019 | 1.6× | −0.9 |
| 2018 | Dec 31, 2018 | 2.4× | +0.7 |
| 2017 | Dec 29, 2017 | 1.7× | +0.2 |
| 2016 | Dec 30, 2016 | 1.5× | −0.3 |
| 2015 | Dec 31, 2015 | 1.8× | +0.1 |
| 2014 | Dec 31, 2014 | 1.7× | +0.2 |
| 2013 | Dec 31, 2013 | 1.5× | +0.7 |
| 2012 | Dec 31, 2012 | 0.8× | −0.0 |
| 2011 | Dec 30, 2011 | 0.8× | −0.7 |
| 2010 | Dec 31, 2010 | 1.5× | – |
See a number that looks wrong?